Smile-Link Healthcare Global Berhad

KLSE:SMILE Stock Report

Mkt Cap: RM45.1m

We’ve recently updated our valuation analysis.

Smile-Link Healthcare Global Berhad Valuation

Is SMILE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SMILE?

Other financial metrics that can be useful for relative valuation.

SMILE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.7x
Enterprise Value/EBITDA24.2x
PEG Ration/a

Price to Sales Ratio vs Peers

How does SMILE's PS Ratio compare to its peers?

The above table shows the PS ratio for SMILE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average5.9x
OPTIMAX Optimax Holdings Berhad
3.7x10.0%RM415.8m
MHCARE Metro Healthcare Berhad
10.2xn/aRM419.4m
TMCLIFE TMC Life Sciences Berhad
3.9xn/aRM1.0b
HONGSENG Hong Seng Consolidated Berhad
5.8xn/aRM1.2b
SMILE Smile-Link Healthcare Global Berhad
1.6xn/aRM45.1m

Price-To-Sales vs Peers: SMILE is good value based on its Price-To-Sales Ratio (1.6x) compared to the peer average (5.9x).


Price to Earnings Ratio vs Industry

How does SMILE's PE Ratio compare vs other companies in the Asian Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a9.2%
n/an/an/a

Price-To-Sales vs Industry: SMILE is good value based on its Price-To-Sales Ratio (1.6x) compared to the Asian Healthcare industry average (1.7x)


Price to Sales Ratio vs Fair Ratio

What is SMILE's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SMILE PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.6x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SMILE's Price-To-Sales Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of SMILE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SMILE (MYR0.2) is trading above our estimate of fair value (MYR0.01)

Significantly Below Fair Value: SMILE is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies